ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, has announced that Dr. Robert Lanza, the Company’s Vice President of Research and Scientific Development, has been recognized for his groundbreaking research and contributions in stem cell science and biology with a special award from Brown University’s Biotechnology Interest Group.
